Article
Vitiligo patients can benefit from any number of therapies offered by dermatologists. One expert discusses the etiologies of this hypopigmentary disorder, its various treatments and its therapeutic challenges.
Tralokinumab Shows Long-Term Efficacy for AD in Sensitive Areas
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
FDA Approves sNDA for Actinic Keratosis Drug Dosage Expansion
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
BREAKING NEWS: Additional Study Confirms Reports of Benzene Presence, Formation in Benzoyl Peroxide Products at Room Temperature
Derm In The News: September 29-October 5